Correlation Between Spectrascience New and AbbVie
Can any of the company-specific risk be diversified away by investing in both Spectrascience New and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spectrascience New and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spectrascience New and AbbVie Inc, you can compare the effects of market volatilities on Spectrascience New and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spectrascience New with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spectrascience New and AbbVie.
Diversification Opportunities for Spectrascience New and AbbVie
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Spectrascience and AbbVie is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Spectrascience New and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and Spectrascience New is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spectrascience New are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of Spectrascience New i.e., Spectrascience New and AbbVie go up and down completely randomly.
Pair Corralation between Spectrascience New and AbbVie
If you would invest 0.00 in Spectrascience New on October 26, 2024 and sell it today you would earn a total of 0.00 from holding Spectrascience New or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 98.31% |
Values | Daily Returns |
Spectrascience New vs. AbbVie Inc
Performance |
Timeline |
Spectrascience New |
AbbVie Inc |
Spectrascience New and AbbVie Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Spectrascience New and AbbVie
The main advantage of trading using opposite Spectrascience New and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spectrascience New position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.Spectrascience New vs. Service Team | Spectrascience New vs. Ehouse Global | Spectrascience New vs. Halitron |
AbbVie vs. Merck Company | AbbVie vs. Pfizer Inc | AbbVie vs. Eli Lilly and | AbbVie vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |